27.09 USD
↘ 0.06 (0.22%)LIVE (AS OF 09:45 AM EST)
Arcutis Biotherapeutics, Inc. Common Stock (ARQT) is currently trading at $27.09. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Furthermore, ARQT is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 16, 2026.